BNBX vs CME · P/E 0.0, rev $2.2M vs P/E 22, rev $3.59B
Applied DNA Sciences, Inc. (BNBX) versus CME Group Inc (CME) — a side-by-side from cached financials, not a winner call.
Applied DNA Sciences, Inc. (BNBX) is a asset management company listed on NASDAQ.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported BNBX revenue for 2026-06-30 was $2.2M. Net income was -$29.9M. Revenue was up 38.1% from 2026-03-31 to 2026-06-30. BNBX currently screens at market cap $3.3M and trailing P/E 0.0.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
BNBX currently screens at market cap $3.3M and trailing P/E 0.0. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Not investment advice. Open the BNBX and CME stock pages for the full models.
Not investment advice.